NEUROENDOCRINE NEOPLASMS
Clinical trials for NEUROENDOCRINE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE NEOPLASMS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted radiation therapy tested for rare, Hard-to-Treat tumors
Disease control Recruiting nowThis study is testing whether a radioactive drug called Lu-177-DOTATATE can safely help control rare adrenal and nerve-related tumors that cannot be removed by surgery. Adults with these specific tumors that show up on a special PET scan will receive four doses of the drug over s…
Matched conditions: NEUROENDOCRINE NEOPLASMS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New pill tested for rare tumors in Real-World setting
Disease control Recruiting nowThis study is testing how well the oral medication surufatinib works for people with advanced neuroendocrine tumors in real-world medical practice. About 350 adult patients will take the pill daily, either alone or combined with other treatments, as determined by their doctors. R…
Matched conditions: NEUROENDOCRINE NEOPLASMS
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New weapon unleashed: immune therapy trial targets Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new drug called BI 764532 for adults with advanced small cell lung cancer or other neuroendocrine cancers that have returned or stopped responding to standard treatments. The main goals are to find a safe and effective dose and to see if the drug can shrin…
Matched conditions: NEUROENDOCRINE NEOPLASMS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Radioactive drug combo aims to zap rare gut tumors
Disease control Recruiting nowThis study is testing whether combining two drugs, Lutathera and Olaparib, can shrink rare neuroendocrine tumors in the digestive system or pancreas that cannot be removed by surgery. About 56 adults will receive Lutathera through an IV every 8 weeks and take Olaparib pills twice…
Matched conditions: NEUROENDOCRINE NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New hope for Tough-to-Treat cancer: experimental drug enters human trials
Disease control Recruiting nowThis early-stage study is testing a new drug called BI 764532, given by IV along with standard chemotherapy, for adults with an aggressive type of neuroendocrine cancer. The main goal is to find the safest and most tolerable dose of the new combination. Researchers will also chec…
Matched conditions: NEUROENDOCRINE NEOPLASMS
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Scientists track cancer drug with special imaging in hopeful patients
Knowledge-focused Recruiting nowThis early study aims to understand how a new drug called BI 764532 moves through the body and into tumors in adults with advanced small cell lung cancer or other neuroendocrine cancers that have stopped responding to standard treatments. Participants receive the drug and then un…
Matched conditions: NEUROENDOCRINE NEOPLASMS
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC